Skip to content
SLQT

SelectQuote, Inc.

SelectQuote, Inc. Q1 FY2025 earnings call

November 4, 2024 · fiscal period ended 2024-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-11-04

Management highlights

  • Strong start to the year with AEP ahead of expectations, leading to increased fiscal 2025 outlook on top- and bottom-line.
  • Senior distribution: High retention of tenured agents, improved agent close rates and productivity, stable policy volume in slow quarter, Medicare Advantage LTV improved to $812.
  • Healthcare Services: SelectRx membership up 64% YOY, sixth straight quarter of profitability, investing in new Olathe, Kansas facility.
  • Balance sheet optimization: $100 million securitization, extended term debt maturities by ~2 years, lower cost of capital, potential for further balance sheet improvement.
View in transcript ↓

Segment performance

Senior distribution: Revenue was $93 million, adjusted EBITDA improved to $8 million. Approved policies were stable year-over-year in a seasonally slow quarter, driven by close rates and agent productivity. Medicare Advantage LTV improved to $812. Healthcare Services (SelectRx): Membership over 86,000, up 64% year-over-year. Revenue $156 million, adjusted EBITDA $5 million (sixth straight quarter of profitability). Life business: Revenue $39 million, adjusted EBITDA grew almost 14%.

View in transcript ↓

Guidance

  • Fiscal 2025 revenue revised to $1.425 billion to $1.525 billion, up from prior range of $1.4 billion to $1.5 billion.
  • Adjusted EBITDA revised to $100 million to $130 million, up from prior range of $90 million to $120 million, driven by first quarter outperformance and AEP expectations.
View in transcript ↓

Risks

  • Uncertainties in forward-looking statements, including those described in earnings release, quarterly report on Form 10-Q for the period ended September 30, 2024, and other SEC filings.
View in transcript ↓

Q&A highlights

Q: Ben Hendrix from RBC Capital Markets asked about balancing policy education and agent productivity in dynamic AEP, and how SelectRx fits in.

A: Tim Danker and Bob Grant responded, discussing increased agent close rates, efficiency through technology and tenured agents, and SelectRx being separate with no extra time for agents.

Q: George Sutton from Craig-Hallum asked about politics in AEP and extension of AEP.

A: Tim Danker and Bill Grant responded, noting strong Q1 results, reduced reliance on TV advertising, and optimism about AEP progress.

Q: Pat McCann from NOBLE Capital Markets asked about technology enhancements and marketing flexibility in Healthcare Services.

A: Bob Grant and Bill Grant responded, discussing agent-led technology, wide funnel marketing flexibility, and potential for acquisitions in healthcare ecosystem.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 4, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.